Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study demonstrates high efficacy of radiotherapy in patients with POEMS syndrome and solitary plasmacytoma and highlights potential benefits of combining radiotherapy (92-100% ORR; 5-year OS 100%, PFS 82%) and immunochemotherapy.”
Title: Efficacy of Radiotherapy and Role of Adjunctive Immunochemotherapy in POEMS Syndrome with Solitary Plasmacytoma
Authors: Grace Lau, Cavitha Vivekananthan, Oliver Tomkins, Karimali Keshwani, Suganya Sivabalasingham, Simon Wan, Michael P Lunn, Shirley D’Sa, Jonathan Sive
You can read the Full Article in Blood Advances.
You can find more posts featuring Robert Orlowski on OncoDaily.
